| 1. |
U. M. Kabadi, Optimal Daily Levothyroxine Dose in Primary Hypothyroidism:
Its Relation to Pretreatment Thyroid Hormone Indexes,@Archives of
Internal Medicine 149 (1989): 2209-12. |
| 2. |
M. I. Surks, Treatment of Hypothyroidism, in Werner
and Ingbar's The Thyroid. 6th ed., edited by Lewis E. Braverman and
R. D. Utiger, 1099-1103 (Philadelphia: Lippincott, 1991). |
| 3. |
E. Roti, R. Minelli and E. Gardini, The Use and Misuse of Thyroid
Hormone, Endocrine Reviews 14, no. 4 (1993): 401-23. |
| 4. |
P. C. Whybrow, Behavioral and Psychiatric Aspects
of Hypothyroidism, in Werner and Ingbar's The Thyroid. 1078-83. |
| 5. |
D. S. Ross, G. H. Daniels, and D. Gouvela, The Use and Limitations
of a Chemiluminescent Thyrotropin Assay as a Single Thyroid Function
Test in an Outpatient Endocrine Clinic, Journal of Clinical Endocrinology
and Metabolism 71, no. 3 (1990): 764-69. |
| 6. |
B. Biondi, S. Fazio, A. Cuocolo, et al., Impaired
Cardiac Reserve and Exercise Capacity in Patients Receiving Long-Term
Thyrotropin Suppressive Therapy with Levothyroxine, Journal of Clinical
Endocrinology and Metabolism 81 (1996): 4224-28. |
| 7. |
B. Uzzan, J. Campos, M. Cucherat, et al., Effects on Bone Mass of
Long-Term Treatment with Thyroid Hormones: A Meta-Analysis, Journal
of Clinical Endocrinology aed Metabolism 81 (1996): 4278-89. |
| 8. |
B. Scholte, B. Nowotny, L. Schaaf, et al., Subclinical
Hyperthyroidism: Physical and Mental State of Patients, European Archives
of Psychiatry aeid Clinical Neuroscience 241(1992): 357-4. |
| 9. |
G. B. Anker, P. E. Lonning, A. Aakvaag, et al., Thyroid Function
in Postmenopausal Breast Cancer Patients Treated with Tamoxifen, Scandinavian
Journal of Clinical Laboratory Investigation 58 (1998): 103-7. |
| 10. |
E. Lesho and R E. Jones, "Hypothyroid Graves'
Disease, Southern Medical Journal 90, no 12(1997): 1201-3. |
| 11. |
N. Takasu, T. Yamada, A Sato, et al., Graves disease following Hypothyroidism
Due to Hashimoto's Disease: Studies of Eight Cases, Clinical Endocrinology
33 (1990): 687-89. |
| 12. |
R. Comtois, L. Faucher, and L. Lafleche, Outcome
of Hypothyroidism Caused by Hashimoto's Thyroiditis, Archives of lnternal
Medicine 155 (1995): 1404-8. |
| 13. |
A. H. Saliby, C. Larosa, R. Rachid, et al., Changes in Levothyroxine
Dose Requirements in the Follow-up of Patients with Primary Hypothyroidism
(abstract presented at the Sixty-ninth Annual Meeting of the American
Thyroid Association, November 13, 1996). |
| 14. |
R. Arem, When to Choose Radioactive lodine, Drugs,
or Surgery, Consultant 28, no. 9 (January 1989): 21-35. |
| 15. |
J. A. Franklyn, The Management of Hyperthyroidism, New Efegland
Journal of Medicine 330, no. 24 (1994): 1731-38. |
| 16. |
N. L. Gittoes and J. A. Franklyn, Hyperthyroidism:
Current Treatment Guidelines, Drugs 55, no. 4 (1998): 543-53. |
| 17. |
J. M. H. Deklerk, J. W. Van Isselt, A. Van Dijk, et al., lodine-131
Therapy in Sporadic Nontoxic Goiter, Journal of Nuclear Medicine 38,
no. 3 (1997): 372-76. |
| 18. |
R. E. Imseis, L. Vanmiddlesworth, J. D. Massie,
et al., Pretreatment with Propylthiouracil but Not Methimazole Reduces
the Therapeutic Efficacy of lodine- 131 in Hyperthyroidism, Journal
of Clinical Endocrinology and Metabolism 83 , no. 2 (1998): 685-87. |
| 19. |
R. A. Hegele and R. Volpe, Relapse of Graves' Disease 23 Years after
Treatment with Radioactive lodine (131-I), Journal of Clinical alid
Laboratory Immunology 18 (1985): 103-5. |
| 20. |
J. A. Franklyn, P. Maisonneuve, M. C. Sheppard,
et al., Mortality after the Treatment of Hyperthyroidism with Radioactive
lodine, New Englaud Journal ofMedicine 338, no. 11 (1998): 712-18. |
| 21. |
L. E. Holrn, P. Hall, K. Wiklund, et al., Cancer Risk after lodine-131
Therapy for Hyperthyroidism, Journal of the National Cancer Institute
83 (1991 ): 1072-77. |
| 22. |
S. T. Tietgens and M. C. Leinung, Thyroid Storm,
Medical Clinics of North America 79, no. I (1995): 169-84. |
| 23. |
M. T. Gladwin and P. B. Duell, Inappropriate Thyroid Gland Ablation
in Patients with Generalized Resistance to Thyroid Hormone, Archives
of Internal Medicine 156, no. 8 (1996): 106-9. |
| 24. |
M. A. Emanuele, M. H. Brooks, D. L. Gordon, et
al., Agoraphobia and Hyperthyroidism, American Journal of Medicine
86 (1989): 484-86. |
| 25. |
S. Benvenga, Benzodiazepine and Remission of Graves' Disease, Thyroid
6, no. 6 (1996): 659-60. |
| 26. |
J. H. Lazarus, Antithyroid Drug Treatment, Clinical
Endocrinology 45 (1996): 517-18. |
| 27. |
A. Toft, Transient Hypothyroidism, Clinical Endocrinology 46 (1997):
7-8. |
| 28. |
D. Glinoer, The Regulation of Thyroid Function
in Pregnancy: Pathways of Endocrine Adaptation from Physiology to
Pathology, Endocrine Reviews 18, no. 3 (1997): 404-33. |
| 29. |
T. Maruo, K. Katayama, H. Matuso, et al., Maintaining Early Pregnancy
in Threatened Abortion, Acta Endocrilrologica 127 (1992): 118-22. |
| 30. |
E. Roti, S. Mindli, and M. Salvi, Management of
Hyperthyroidism and Hypothyroidism in the Pregnant Woman, Journal
of Clinical Endocrinology and Metabolism 81, no. 5 (1996): 1679-82. |
|